2018 Translational Imaging Symposium
Boston Convention and Exhibition Center, Room 102-A/B, 415 Summer Street, Boston, MA 02210
June 21, 2018
Please join Invicro, and WMIS for the annual Translational Imaging Symposium: Quantitative Biomarkers in Drug Discovery and Development: Genomics – Pathology – Imaging
Come network with industry leaders and attend thought-provoking seminars and discussions hosted by top influencers within the translational imaging and precision medicine space. Leaders in quantitative biomarkers will present on the latest innovations and emerging global trends in the field. We anticipate over 150 peers, collaborators and like-minded professionals to partake in array of educational and informational presentations ranging from therapeutic- and modality-specific quantitative biomarker approaches to more general biomarker strategies for advancing drug candidates through the clinic. Please join us- we look forward to hosting you at this complimentary one-day event.
Registration and Breakfast 7:30 am – 8:15 am
Speakers 8:15 am – 5:00 pm
Exhibits Open 7:30 am – 4:00 pm
Reception at Invicro (Micro Brew Tasting Event by our colleagues) 5:00 pm to 8:30 pm
Jeff Evelhoch, Vice President, Head of Translational Biomarkers at Merck
Matthew Silva, PhD, Vertex Pharmaceuticals
Dr. R. Adam Smith, Bristol-Myers Squibb
Dr. Kenneth Bloom, Invicro
Dr. Karl Schmidt, Celgene Corp
David Leung, MD, PhD, Bristol-Myers Squibb
R. Nick Bryan, MD, PhD, The University of Texas at Austin
Roger Gunn, PhD, Invicro
Richard E. Carson, PhD, Yale University
Registration is free of charge. Complimentary breakfast and lunch will be provided. Invicro will host a reception with drinks and appetizers following the meeting from 5:00 pm to 8:30 pm.
For more information, please contact us.